Amylyx Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Amylyx Pharmaceuticals

09/08/2024 17:14

* Amylyx Pharmaceuticals Inc  AMLX.OQ  reported a quarterly
adjusted loss of 73 cents​​ per share for the quarter ended in
June, lower than the same quarter last year, when the company
reported EPS of 31 cents.  The mean expectation of five analysts
for the quarter was for a loss of 73 cents per share. Wall
Street expected results to range from $-1.08 to -24 cents per
share.
    * Revenue rose 101% to $-1.02 million from a year ago;
analysts
expected $10.66 million. 
    * Amylyx Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $1.07​.
    * The company reported a quarterly loss of $72.7 million.
    * Amylyx Pharmaceuticals Inc shares had fallen by 5.3% this
quarter and lost 87.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "hold"

Wall Street's median 12-month price target for Amylyx
Pharmaceuticals Inc is $3.75 
This summary was machine generated from LSEG data August 9 at
04:14 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.73          -0.73          Met
 Mar. 31 2024      -0.01          -0.12          Missed
 Dec. 31 2023      0.23           0.07           Missed
 Sep. 30 2023      0.44           0.30           Missed